Monthly Digest – August 2024 Monthly Digest – August 2024 28 Aug 2024: Enfortumab vedotin plus pembrolizumab approved in Europe for urothelial carcinoma The European Commission (EC) has approved the combination of enfortumab vedotin-ejfv (EV, Padcev) and pembrolizumab (Keytruda) for […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id